🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/11/2016 | 59,70 | 59,75 | 58,90 | 59,04 | -1,32% | 1,42% | 8.066.351 |
| 17/11/2016 | 59,65 | 59,91 | 59,27 | 59,83 | +0,11% | 1,07% | 8.762.642 |
| 16/11/2016 | 60,78 | 61,02 | 59,59 | 59,76 | -1,60% | 2,35% | 11.297.650 |
| 15/11/2016 | 60,76 | 60,81 | 60,19 | 60,73 | +0,19% | 1,02% | 7.640.339 |
| 14/11/2016 | 61,07 | 61,15 | 60,34 | 60,62 | -0,66% | 1,33% | 10.610.476 |
| 11/11/2016 | 61,15 | 61,56 | 60,67 | 61,02 | -1,55% | 1,45% | 14.734.566 |
| 10/11/2016 | 61,58 | 62,46 | 61,56 | 61,98 | +1,22% | 1,46% | 18.719.690 |
| 09/11/2016 | 61,03 | 62,02 | 59,89 | 61,24 | +6,07% | 3,50% | 29.187.953 |
| 08/11/2016 | 57,08 | 58,00 | 56,79 | 57,74 | +0,77% | 2,11% | 8.323.321 |
| 07/11/2016 | 56,79 | 57,45 | 56,76 | 57,30 | +2,09% | 1,23% | 10.981.258 |
| 04/11/2016 | 56,00 | 56,56 | 55,93 | 56,13 | +0,67% | 1,12% | 11.861.893 |
| 03/11/2016 | 56,47 | 56,51 | 55,62 | 55,75 | -0,70% | 1,57% | 11.866.504 |
| 02/11/2016 | 56,36 | 56,78 | 56,06 | 56,15 | -0,78% | 1,29% | 11.239.486 |
| 01/11/2016 | 56,30 | 56,86 | 55,83 | 56,58 | +0,99% | 1,83% | 15.036.075 |
| 31/10/2016 | 56,38 | 56,44 | 55,70 | 56,03 | -0,20% | 1,32% | 14.939.030 |
| 28/10/2016 | 58,23 | 58,27 | 55,77 | 56,15 | -4,00% | 4,29% | 21.335.603 |
| 27/10/2016 | 58,35 | 59,22 | 58,21 | 58,48 | +0,69% | 1,73% | 10.847.534 |
| 26/10/2016 | 58,91 | 59,02 | 57,78 | 58,08 | -1,74% | 2,11% | 10.435.774 |
| 25/10/2016 | 57,51 | 59,34 | 56,82 | 59,11 | +1,98% | 4,38% | 15.917.548 |
| 24/10/2016 | 58,59 | 58,66 | 57,86 | 57,97 | -0,74% | 1,37% | 10.420.264 |
| 21/10/2016 | 58,73 | 59,06 | 58,23 | 58,40 | -1,16% | 1,41% | 7.762.222 |
| 20/10/2016 | 59,11 | 59,42 | 58,86 | 59,08 | +0,08% | 0,94% | 6.626.923 |
| 19/10/2016 | 59,28 | 59,45 | 58,98 | 59,04 | -0,35% | 0,79% | 5.850.670 |
| 18/10/2016 | 59,06 | 59,75 | 59,00 | 59,25 | +0,93% | 1,28% | 10.467.424 |
| 17/10/2016 | 59,21 | 59,21 | 58,02 | 58,70 | -1,00% | 2,01% | 13.681.221 |
| 14/10/2016 | 59,85 | 59,98 | 59,28 | 59,29 | -0,59% | 1,16% | 12.790.002 |
| 13/10/2016 | 59,40 | 60,07 | 59,10 | 59,65 | +1,38% | 1,62% | 15.239.492 |
| 12/10/2016 | 59,54 | 59,76 | 58,76 | 58,84 | -0,44% | 1,68% | 10.607.751 |
| 11/10/2016 | 60,62 | 60,64 | 58,92 | 59,09 | -3,08% | 2,83% | 14.625.259 |
| 10/10/2016 | 61,27 | 61,89 | 60,53 | 60,97 | +1,80% | 2,21% | 21.322.503 |